tetano
Editor, Senior Moderator
J Immunol
. 2022 Jan 31;ji2101052.
doi: 10.4049/jimmunol.2101052. Online ahead of print.
Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine
Alexey A Komissarov[SUP] 1 [/SUP], Inna V Dolzhikova[SUP] 2 [/SUP], Grigory A Efimov[SUP] 3 [/SUP], Denis Y Logunov[SUP] 2 [/SUP], Olga Mityaeva[SUP] 4 [/SUP], Ivan A Molodtsov[SUP] 5 [/SUP], Nelli B Naigovzina[SUP] 6 [/SUP], Iuliia O Peshkova[SUP] 3 [/SUP], Dmitry V Shcheblyakov[SUP] 2 [/SUP], Pavel Volchkov[SUP] 4 7 [/SUP], Alexander L Gintsburg[SUP] 2 [/SUP], Elena Vasilieva[SUP] 5 6 [/SUP]
Affiliations
Abstract
Despite measures taken world-wide, the coronavirus disease 2019 (COVID-19) pandemic continues. Because efficient antiviral drugs are not yet widely available, vaccination is the best option to control the infection rate. Although this option is obvious in the case of COVID-19-naive individuals, it is still unclear when individuals who have recovered from a previous SARS-CoV-2 infection should be vaccinated and whether the vaccination raises immune responses against the coronavirus and its novel variants. In this study, we collected peripheral blood from 84 healthy human donors of different COVID-19 status who were vaccinated with the Sputnik Light vaccine and measured the dynamics of the Ab and T cell responses, as well as the virus-neutralizing activity (VNA) in serum, against two SARS-CoV-2 variants, B.1.1.1 and B.1.617.2. We showed that vaccination of individuals previously exposed to the virus considerably boosts the existing immune response. In these individuals, receptor-binding domain (RBD)-specific IgG titers and VNA in serum were already elevated on the 7th day after vaccination, whereas COVID-19-naive individuals developed the Ab response and VNA mainly 21 d postvaccination. Additionally, we found a strong correlation between RBD-specific IgG titers and VNA in serum, and according to these data vaccination may be recommended when the RBD-specific IgG titers drop to 142.7 binding Ab units/ml or below. In summary, the results of the study demonstrate that vaccination is beneficial for both COVID-19-naive and recovered individuals, especially since it raises serum VNA against the B.1.617.2 variant, one of the five SARS-CoV-2 variants of concern.
. 2022 Jan 31;ji2101052.
doi: 10.4049/jimmunol.2101052. Online ahead of print.
Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine
Alexey A Komissarov[SUP] 1 [/SUP], Inna V Dolzhikova[SUP] 2 [/SUP], Grigory A Efimov[SUP] 3 [/SUP], Denis Y Logunov[SUP] 2 [/SUP], Olga Mityaeva[SUP] 4 [/SUP], Ivan A Molodtsov[SUP] 5 [/SUP], Nelli B Naigovzina[SUP] 6 [/SUP], Iuliia O Peshkova[SUP] 3 [/SUP], Dmitry V Shcheblyakov[SUP] 2 [/SUP], Pavel Volchkov[SUP] 4 7 [/SUP], Alexander L Gintsburg[SUP] 2 [/SUP], Elena Vasilieva[SUP] 5 6 [/SUP]
Affiliations
- PMID: 35101893
- DOI: 10.4049/jimmunol.2101052
Abstract
Despite measures taken world-wide, the coronavirus disease 2019 (COVID-19) pandemic continues. Because efficient antiviral drugs are not yet widely available, vaccination is the best option to control the infection rate. Although this option is obvious in the case of COVID-19-naive individuals, it is still unclear when individuals who have recovered from a previous SARS-CoV-2 infection should be vaccinated and whether the vaccination raises immune responses against the coronavirus and its novel variants. In this study, we collected peripheral blood from 84 healthy human donors of different COVID-19 status who were vaccinated with the Sputnik Light vaccine and measured the dynamics of the Ab and T cell responses, as well as the virus-neutralizing activity (VNA) in serum, against two SARS-CoV-2 variants, B.1.1.1 and B.1.617.2. We showed that vaccination of individuals previously exposed to the virus considerably boosts the existing immune response. In these individuals, receptor-binding domain (RBD)-specific IgG titers and VNA in serum were already elevated on the 7th day after vaccination, whereas COVID-19-naive individuals developed the Ab response and VNA mainly 21 d postvaccination. Additionally, we found a strong correlation between RBD-specific IgG titers and VNA in serum, and according to these data vaccination may be recommended when the RBD-specific IgG titers drop to 142.7 binding Ab units/ml or below. In summary, the results of the study demonstrate that vaccination is beneficial for both COVID-19-naive and recovered individuals, especially since it raises serum VNA against the B.1.617.2 variant, one of the five SARS-CoV-2 variants of concern.